NCT00224055 - Effect of Ferrlecit® Versus Oral Iron on Iron Deficient Chronic Kidney Disease (CKD) Patients | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

April 30, 2003

Primary Completion Date

September 30, 2004

Study Completion Date

September 30, 2004

Conditions

Anemia, Iron-DeficiencyKidney Failure, Chronic

Interventions

DRUG

Sodium Ferric Gluconate Complex in Sucrose Injection

Sodium Ferric Gluconate Complex in Sucrose Injection (Ferrlecit®), 250 mg IV weekly for 4 weeks

DRUG

Ferrous sulfate tablets

ferrous sulfate, 325 mg oral, three times daily for 6 weeks

Trial Locations (24)

Tucson

Los Angeles

Palo Alto

San Diego

Hines

Indianapolis

Shreveport

Baltimore

Springfield

Detroit

St Louis

Birmingham

Mineola

New York

The Bronx

Chapel Hill

Cleveland

Philadelphia

Charlotte

Chattanooga

Memphis

Houston

Fairfax

San Juan